Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
3 weeks ago
Video Series
Author(s):
Inés Martínez-Salgado
,
Manuel Sánchez
,
Diego De la Eranueva Calvo
,
et al
Added:
1 month ago
SGLT2 Inhibitors in Acute Heart Failure
Author(s):
Hugo Prado-Prado
,
Sergio Raposeiras-Roubín
Added:
3 months ago
Viewpoint
Marco Metra
Research Area(s) / Expertise:
Job title: Professor
Author
Ovidiu Chioncel
Research Area(s) / Expertise:
Job title: Professor of Cardiology, Head of ICCU
Author
Targeting Obesity for Heart Failure
Author(s):
Emily Morris
,
Oliver J Rider
Added:
5 months ago
Review Article
Kevin Damman
Research Area(s) / Expertise:
Job title: Head of the Heart Transplant and Left Ventricular Device Program
Author
Jozine ter Maaten
Research Area(s) / Expertise:
Job title: Cardiologist
Author
Veli-Pekka Harjola
Research Area(s) / Expertise:
Job title: Associate Chief Physician and Cardiologist
Author
Author(s):
James Udelson
Added:
1 year ago
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the…
View more